Skip to main content

Table 1 Sociodemographic and clinical variables according to the absence (N = 37)/presence (N = 23) of metabolic syndrome

From: Perceived needs and health-related quality of life in people with schizophrenia and metabolic syndrome: a “real-world” study

MetS No Yes t/Chi2(A) p
Age (mean, SD) 41.7 (10.9) 46.0 (10.1) 1.54 .130
Sex (N = 60)    .582 .445
 Male 62.2 % 52.2 %
 Female 37.8 % 47.8 %
Employment Status (N = 60)    .353 .553
 Active 18.9 % 13.0 %
 Unemployed 81.1 % 87.0 %
Living Arrangements    .023 .879
 Living with parents 86.5 % 91.3 %
 Others 13.5 % 8.7 %
Education (N = 60)    .244 .622
 Primary school 37.8 % 43.5 %
 Secondary school 24.3 % 17.4 %
 Medium studies (professional college) 18.9 % 30.4 %
 University 18.9 % 8.7 %
Years since diagnosis (N = 59)    .570 .450
 Less than 5 years 19.4 % 8.7 %
 5-10 years 6.0 % 21.7 %
 10-15 years 22.2 % 21.7 %
 More than 15 years 41.7 % 47.8 %
Lifestyle habits (N = 60)     
 Smoking 56.8 % 73.9 % 1.79 .180
 Alcoholism 24.3 % 26.1 % .024 .878
 Abuse of other substances/drugs(B) 29.7 % 17.4 % 1.15 .283
Diet (N = 59)     
 Unrestricted calories 80.6 % 65.2 % 1.74 .187
 Unrestricted salt 66.7 % 56.5 % .618 .432
 Unrestricted fibers 66.7 % 65.2 % .013 .909
 Unrestricted saturated fat 44.4 % 26.1 % 2.02 .155
 Physical activity 69.4 % 65.2 % .115 .735
Medical history (N = 60)     
 Cardiovascular disease 2.7 % 30.4 % 9.44 .002
 Dyslipidemia 8.1 % 30.4 % 5.09 .024
 Diabetes mellitus 13.5 % 43.5 % 6.79 .009
Psychopharmacological Treatment (N = 60)     
Antipsychotics (AP)- Monotherapy 54.1 % 30.4 % 3.19 .074
Antipsychotics (AP)- Polytherapy 45.9 % 69.6 %
Antidepressants (AD) 40.5 % 39.1 % .012 .914
Anxiolytics/Hypnotics (AN) 59.5 % 69.6 % .624 .430
Mood stabilizers (MS) 32.4 % 43.5 % .745 .388
Others(C) 21.6 % 26.1 % .158 .691
  1. (A): Student’s t for mean comparison; Chi2 for nominal and Mantel-Haenszel for ordinal variables
  2. (B): Caffeine, cannabis, cocaine, hypnotics
  3. (C): Anticholinergics, treatment for alcohol dependence (naltrexone and dissulfiram)